From Functional Group and Metabolite Analysis to Rational Design: Discovery of BXY-14 as a Highly Potent TLR2 Agonist with Enhanced Vaccine Adjuvants and Cancer Immunotherapy.

Summary: Our immune system has a special sensor called TLR2 that helps fight off sickness. Scientists found a natural compound that acts like a "sleeping" helper for this sensor. When this compound enters a stressful, oxygen-rich area—like near a tumor—it wakes up and powerfully boosts the immune system. Using this clue, researchers designed a brand-new drug called BXY-14. This new drug works great as a partner for vaccines and helps the body fight cancer!